Showing results (111-120 of 279) with videos related to

Sort By:
Pageof 28
Inflammatory Intestinal Diseases|February 5, 2025
A Pilot Study Using a Smartwatch to Search for Biomarkers of Heart Rate Variability in Active Ulcerative ColitisJin Imai, Masashi Ohno, Masaya Sano, et al.
Inflammatory Intestinal Diseases|December 11, 2024
The Role of Esophageal Physiologic Tests in Eosinophilic EsophagitisJeanine Wakim El-Khoury, Ekaterina Safroneeva, Alain M Schoepfer
Inflammatory Intestinal Diseases|October 30, 2023
Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative ColitisGenta Uchida, Masanao Nakamura, Takeshi Yamamura, et al.
Inflammatory Intestinal Diseases|October 30, 2023
Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative ColitisKazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima, et al.
Inflammatory Intestinal Diseases|March 2, 2026
Upadacitinib Treatment Outcomes in Crohn's Disease: A Retrospective Analysis of Clinical Response and Perianal Fistula ResolutionJunya Shiota, Moto Kitayama, Hiroko Inomata, et al.
Inflammatory Intestinal Diseases|May 4, 2026
Leucine-Rich Alpha-2 Glycoprotein Is an Accurate Serum Marker for Endoscopic and Histological Remission in Ulcerative ColitisAmi Kawamoto, Toshimitsu Fujii, Shohei Tanaka, et al.
Inflammatory Intestinal Diseases|May 8, 2026
Clinical Characteristics of Crohn's Disease-Associated Cancer with a Focus on Endoscopic SurveillanceYumie Kobayashi, Shuhei Hosomi, Koji Fujimoto, et al.
Inflammatory Intestinal Diseases|June 1, 2026
Individual Variations in Anti-αvβ6 Autoantibody Levels Determined by ITGAV Gene Polymorphisms: Associations with Genetic Background and Relapse in Ulcerative ColitisSatoshi Ono, Yoshiharu Yamaguchi, Akane Sugimura, et al.
Inflammatory Intestinal Diseases|June 29, 2026
Interleukin Signatures as Histology-Aligned Biomarkers in Inflammatory Bowel DiseaseNikolaos Martinos, Andreas C Lazaris, Christos Kroupis, et al.
Inflammatory Intestinal Diseases|July 10, 2026
Efficacy of Ustekinumab on Skin Reactions Induced by Tumor Necrosis Factor-Alpha Inhibitors in Patients with Inflammatory Bowel DiseaseKoji Fujimoto, Shuhei Hosomi, Yumie Kobayashi, et al.
Pageof 28